Cxbladder is a non-invasive test for the detection of bladder cancer that gives you actionable results that can make a meaningful difference in your patient's treatment.

The Cxbladder technology comprises proprietary, accurate molecular testing of genomic biomarkers (mRNA) from a small volume of patients’ urine, and patient clinical characteristics enabling the non-invasive detection of bladder and other urinary tract cancers (urothelial carcinoma).

The Cxbladder suite of products provides a ‘one-stop shop’ for clinicians in the primary detection and post-treatment management of urothelial carcinoma (UC).

cxbladder family of products